-
Clarus Therapeutics Defeats Lipocine's Patent Infringement Lawsuit On Summary Judgment
26 May 2021 07:10 GMT
… of Blue Water for its initial public offering dated December 16, 2020 and … Investor Relations Contact:
Ric Peterson
Clarus Therapeutics, Inc.
555 Skokie Blvd., … .com/news-releases/clarus-therapeutics-defeats-lipocines-patent-infringement-lawsuit …
-
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
08 Oct 2021 11:49 GMT
… SXT Pharmaceuticals, Inc. (NASDAQ: SXTC)
Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT)
Concert … follow up.
IPOs
IsoPlexis Corporation (NASDAQ: ISO) priced its initial public offering of 8 … Arix Bioscience plc, priced its IPO of 10.5 million shares …
-
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
01 Oct 2021 12:43 GMT
… )
Chemomab Therapeutics Ltd. (NASDAQ: CMMB)
Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT)
CNS … Phase 3 study of AZD1222
IPOs
Exscientia plc (NASDAQ: EXAI), an … pharmatech company, priced its upsized initial public offering of 13.85 million ADSs …
-
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
15 Jul 2021 12:30 GMT
… settlement and license agreement with Clarus Therapeutics to resolve all outstanding claims … Test Awaits FibroGen, Data Readouts, IPOs In The Mix
MorphoSys Consummates … )
IPO
Salt Lake City, Utah-based Sera Prognostics, Inc. priced its initial public offering …
-
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
… amp; Marketing Network) -- Clarus Therapeutics Inc. announced today the … private and public financings (IPOs). He also brings to … and Sienna completed successful IPOs. While at Medicis, he … www.JATENZO.com.
About Clarus Therapeutics
Clarus is a specialty …
-
Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday
30 Aug 2022 13:00 GMT
… 65. PaxMedica priced its initial public offering of 1.55 million shares … proceeds towards debt repayment.
Clarus Therapeutics Holdings, Inc. CRXT shares … at $0.1570. Clarus Therapeutics recently reported its Q2 … company recently priced its IPO at $$4.13 per …
-
Turn Biotechnologies Names 25-year Biotech Industry Veteran Richard Peterson Chief Financial Officer
03 Nov 2022 05:51 GMT
… clinical stage biopharmaceutical companies, including Clarus Therapeutics, Sienna Biopharmaceuticals, Dermavant Sciences Inc … , Novan and Sienna completed successful IPOs. At Medicis, he helped lead …
-
Why Nikola Dropped Over 9%; Here Are 66 Biggest Movers From Yesterday
31 Aug 2022 11:23 GMT
… 6.2 million public offering.
Clarus Therapeutics Holdings, Inc. CRXT fell … at $0.0990. Clarus Therapeutics shares dipped 23% on … stock surged following its IPO.
Starbox Group Holdings Ltd … stock sees volatility following its IPO last Tuesday.
Cabaletta Bio …
-
Why IN8bio Is Trading Higher By 46%, Here Are 54 Stocks Moving In Tuesday's Mid-Day Session
30 Aug 2022 18:07 GMT
… the stock surged following its IPO.
Sentage Holdings Inc. SNTG … stock sees volatility following its IPO last Tuesday.
Cabaletta Bio, … from $22 to $5.
Clarus Therapeutics Holdings, Inc. CRXT fell 17 … 5% to $0.1295. Clarus Therapeutics shares dipped 23% on Monday …
-
Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday
22 Aug 2022 08:12 GMT
… following the company's IPO on Thursday.
Aeglea BioTherapeutics, Inc … valued at approximately $8 million.
Clarus Therapeutics Holdings, Inc. CRXT dropped 27 … to close at $0.2062. Clarus Therapeutics posted a Q2 loss of …
About
© 1995-2024